8th Apr 2014 18:10
8 April 2014
TyraTech, Inc.
("TyraTech" or the "Company")
Director's Dealings
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences company, announces that, it was notified today that, on 7 April 2014, Mr Alan Reade and his wife, Mrs Alyson Reade, sold 202,500 Common shares of US$0.001 per share (AIM: TYR) ("TyraTech shares"); at a price of 11.80 pence per TyraTech share.
Mr & Mrs Reade then immediately repurchased 197,500 Common shares at 11.82 pence per TyraTech share; these shares being acquired equally into their respective ISA accounts.
Following these transactions, Alan Reade's beneficial interest in the Company has reduced by 5,000 TyraTech shares to 12,481,358 TyraTech shares representing approximately 6.09% of the Company's issued share capital.
For further information please contact:
TyraTech Inc.Alan Reade, Non-Executive ChairmanBruno Jactel, Chief Executive Officer | Tel: +44 7841978709Tel: +1 919 415 4340 |
SPARK Advisory Partners Limited, Nominated AdviserMatt Davis / Mark Brady | Tel: +44203 368 3552 Tel: +44203 368 3551 |
Allenby Capital Limited , Joint BrokerChris Crawford | Tel: +44 20 3328 5656 |
Whitman Howard Limited, Joint BrokerRanald McGregor-Smith / Niall Devins | Tel: +44 20 7087 4555 |
Walbrook, Financial PR and IRBob Huxford /Guy McDougall (Public Relations)Paul Cornelius (Investor Relations) | Tel: +44 20 7933 8792Tel: +44 20 7933 8794 |
Related Shares:
TyratechTyratech Com Shares